Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain

Brief Summary

Once patients' postoperative pain intensity reaches a moderate-to-severe level, they are randomized to receive intranasal ketamine or placebo. Patients remain in the study unit for 3 hours post administration and assess pain intensity and pain relief throughout the 3 hour postoperative period.

Intervention / Treatment

  • Drug: intranasal ketamine
  • Drug: Placebo

Condition or Disease

  • Pain, Postoperative

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 16 Years and older   (Child, Adult, Older Adult)
Enrollment: 40 ()
Funded by: Industry

Masking

Clinical Trial Dates

Start date: Mar 01, 2020
Primary Completion: Apr 01, 2020
Completion Date: Apr 01, 2020
Study First Posted: Jun 20, 2007
Results First Posted: Aug 31, 2020
Last Updated: Feb 07, 2008

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Eligibility Criteria

Sex: All
Minimum Age: 16

More Details

NCT Number: NCT00488787
Other IDs: KET-003
Study URL: https://ClinicalTrials.gov/show/NCT00488787
Last updated: Feb 22, 2021